Residual SYNTAX score and optical coherence tomography–derived thin-cap fibroatheroma in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: an exploratory descriptive pilot study
- 1Department of Cardiology, Nizam’s Institute of Medical Sciences, Hyderabad, India
Abstract
Background: ST-elevation myocardial infarction (STEMI) remains a leading cause of global morbidity and mortality. While percutaneous coronary intervention (PCI) is the definitive reperfusion strategy, residual disease burden and plaque vulnerability both influence clinical recovery. The residual SYNTAX score (rSS) quantifies untreated macroscopic coronary artery disease, whereas optical coherence tomography (OCT) resolves microscopic plaque architecture, notably thin-cap fibroatheroma (TCFA). This pilot study explored the descriptive characteristics and short-term outcomes associated with combining rSS and OCT-derived TCFA in a highly selected STEMI cohort.
Methods: This retrospective observational pilot study included 30 patients with STEMI who underwent primary PCI and culprit lesion OCT evaluation at a tertiary care center. Patients were stratified into four groups according to the presence of culprit TCFA and the post-PCI rSS threshold (≤≤ 4 vs. > 4): group 0 (TCFA absent, rSS > 4), group 1 (TCFA absent, rSS ≤≤ 4), group 2 (TCFA present, rSS > 4), and group 3 (TCFA present, rSS ≤≤ 4). The primary clinical endpoint was major adverse cardiac events (MACE)—a composite of all-cause death, recurrent myocardial infarction, target lesion revascularization, heart failure hospitalisation, and ischemic stroke—assessed over 3 months.
Results: The cohort (mean age, 54.5 ± 10.1 years; 83.3% male, 40% with diabetes mellitus) had a 53.3% prevalence (16 of 30) of culprit lesion TCFA. Complete or reasonable revascularization (rSS ≤ 4) was achieved in 12 patients (40.0%). The overall cumulative 3-month MACE rate was 30.0% (9 of 30). MACE occurred in 1 of 7 patients (14.3%) in group 0, 1 of 7 (14.3%) in group 1, 4 of 11 (36.4%) in group 2, and 3 of 5 (60.0%) in group 3 (Fisher exact test, P = 0.23; log-rank P = 0.38). Patients with TCFA accounted for 7 of 9 clinical events (77.8%). Given the small subgroup sizes (n < 12), multivariable predictive risk modeling was not performed.
Conclusions: In this exploratory pilot cohort of STEMI patients undergoing PCI, the presence of OCT-derived TCFA was descriptively associated with higher short-term adverse event rates across both complete and incomplete revascularization strata. Given the small sample size and clear indication bias, these findings are strictly hypothesis-generating and support the need for adequately powered prospective registries to evaluate dual anatomical-biological risk stratification.
Related
- Antiplatelet Therapy Strategies in Patients with High Bleeding Risk Treated with Complex Percutaneous Coronary Intervention: A Descriptive Study
- From coronary computed tomography angiography to the cath lab: computed tomography-guided percutaneous coronary intervention of a high-risk left anterior descending artery lesion
- Artificial Intelligence‐Assisted Automated Optical Coherence Tomography Analysis for Percutaneous Coronary Intervention Planning: From Plaque Analysis to Precision Lesion Preparation and Stent Optimization
- Single-Stage Computed Tomography Angiography, Percutaneous Coronary Intervention, and Transcatheter Aortic Valve Replacement in an Octogenarian With Femoral Neck Fracture, Non-ST-Elevation Myocardial Infarction, and Severe Aortic Stenosis: A Case Report and Literature Review of Multidisciplinary Approaches
- Recovery experiences and perceptions of quality of life after percutaneous coronary intervention for ST-elevation myocardial infarction: An interpretive descriptive qualitative study
BibTeX
@article{syed2026residual,
title = {{Residual SYNTAX score and optical coherence tomography–derived thin-cap fibroatheroma in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: an exploratory descriptive pilot study}},
author = {Meharunnisha Syed and Uma Devi Karuru and Sunitha Arumulla and Neusha Doddi and Pradeep Rongali and Rama Kumari Nuthalapati},
journal = {Journal of Cardiovascular Imaging},
year = {2026},
month = oct,
doi = {10.1186/s44348-026-00104-6},
url = {https://doi.org/10.1186/s44348-026-00104-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Residual SYNTAX score and optical coherence tomography–derived thin-cap fibroatheroma in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: an exploratory descriptive pilot study
AU - Meharunnisha Syed
AU - Uma Devi Karuru
AU - Sunitha Arumulla
AU - Neusha Doddi
AU - Pradeep Rongali
AU - Rama Kumari Nuthalapati
PY - 2026
DA - 2026/10/26
JO - Journal of Cardiovascular Imaging
DO - 10.1186/s44348-026-00104-6
UR - https://doi.org/10.1186/s44348-026-00104-6
AB - Background: ST-elevation myocardial infarction (STEMI) remains a leading cause of global morbidity and mortality. While percutaneous coronary intervention (PCI) is the definitive reperfusion strategy, residual disease burden and plaque vulnerability both influence clinical recovery. The residual SYNTAX score (rSS) quantifies untreated macroscopic coronary artery disease, whereas optical coherence tomography (OCT) resolves microscopic plaque architecture, notably thin-cap fibroatheroma (TCFA). This pilot study explored the descriptive characteristics and short-term outcomes associated with combining rSS and OCT-derived TCFA in a highly selected STEMI cohort. Methods: This retrospective observational pilot study included 30 patients with STEMI who underwent primary PCI and culprit lesion OCT evaluation at a tertiary care center. Patients were stratified into four groups according to the presence of culprit TCFA and the post-PCI rSS threshold (≤≤ 4 vs. > 4): group 0 (TCFA absent, rSS > 4), group 1 (TCFA absent, rSS ≤≤ 4), group 2 (TCFA present, rSS > 4), and group 3 (TCFA present, rSS ≤≤ 4). The primary clinical endpoint was major adverse cardiac events (MACE)—a composite of all-cause death, recurrent myocardial infarction, target lesion revascularization, heart failure hospitalisation, and ischemic stroke—assessed over 3 months. Results: The cohort (mean age, 54.5 ± 10.1 years; 83.3% male, 40% with diabetes mellitus) had a 53.3% prevalence (16 of 30) of culprit lesion TCFA. Complete or reasonable revascularization (rSS ≤ 4) was achieved in 12 patients (40.0%). The overall cumulative 3-month MACE rate was 30.0% (9 of 30). MACE occurred in 1 of 7 patients (14.3%) in group 0, 1 of 7 (14.3%) in group 1, 4 of 11 (36.4%) in group 2, and 3 of 5 (60.0%) in group 3 (Fisher exact test, P = 0.23; log-rank P = 0.38). Patients with TCFA accounted for 7 of 9 clinical events (77.8%). Given the small subgroup sizes (n < 12), multivariable predictive risk modeling was not performed. Conclusions: In this exploratory pilot cohort of STEMI patients undergoing PCI, the presence of OCT-derived TCFA was descriptively associated with higher short-term adverse event rates across both complete and incomplete revascularization strata. Given the small sample size and clear indication bias, these findings are strictly hypothesis-generating and support the need for adequately powered prospective registries to evaluate dual anatomical-biological risk stratification.
SN - 2586-7210
SN - 2586-7296
ER -